Isracann Biosciences Inc. filed its Annual on Nov 30, 2022 for the period ending May 31, 2022. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | -.--% | -.--% | -.--% |
04-26 | Isracann Biosciences Inc. Announces Resignation of Directors | CI |
01-23 | Isracann Biosciences Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.94M | |
+45.15% | 6.34B | |
-14.00% | 4.61B | |
+9.54% | 3.39B | |
-8.99% | 3.29B | |
+50.03% | 2.02B | |
-6.97% | 1.73B | |
-0.31% | 1.67B | |
+50.00% | 1.63B | |
-10.61% | 1.59B |
- Stock Market
- Equities
- IPOT Stock
- News Isracann Biosciences Inc.
- Isracann Biosciences Inc. Auditor Raises 'Going Concern' Doubt